JP Patent

JP4413493B2 — プリンｌｎａ類似体の改善された合成方法

Assigned to Roche Innovation Center Copenhagen AS · Expires 2010-02-10 · 16y expired

What this patent protects

Patent listed against givosiran-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP4413493B2
Jurisdiction
JP
Classification
—
Expires
2010-02-10
Drug substance claim
No
Drug product claim
No
Assignee
Roche Innovation Center Copenhagen AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.